Sleep evidence guide11 min read

Best Herbs for Sleep: What Human Evidence Supports in 2026

By

Last evidence review: Report a correction

Evidence-first guide to ashwagandha, passionflower, valerian, chamomile, and lavender-related sleep evidence, with directness, safety limits, and chronic-insomnia guidance.

Herbs commonly marketed for sleep arranged for an evidence comparison
Traditional use, plausible mechanisms, and retail popularity are not substitutes for direct insomnia evidence.

Bottom line

There is no evidence-based “first herb” for every sleep problem

Ashwagandha has a small pooled sleep signal from five placebo-controlled trials, but the evidence is preparation-specific and multi-week. Passionflower has one useful but preliminary insomnia trial. Those findings are more direct than tradition alone, but neither supports a same-night winner rule.

Valerian and chamomile remain weaker than their popularity suggests. A 2024 valerian umbrella review found no evidence of efficacy for treating insomnia, and NCCIH says chamomile evidence is not conclusive. Lavender-related aromatherapy research is a different intervention from taking an oral lavender supplement.

This table scrolls horizontally on small screens. Use Tab to focus the table region, then scroll with arrow keys or touch.

OptionDirect human sleep evidenceMain limitInterpretation
Ashwagandha2021 meta-analysis: 5 placebo-controlled RCTs / 400 adults using specific standardized extracts over repeated multi-week regimens.Small pooled effect, moderate heterogeneity, preparation-specific evidence, and limited long-term safety data.Limited sleep signal.
Passionflower110 adults with DSM-5 insomnia, passionflower extract vs placebo for 2 weeks; total sleep time improved between groups.Several other sleep outcomes did not differ between groups; one short trial cannot establish broad efficacy.Preliminary.
Valerian2024 umbrella review included 8 systematic reviews and found some subjective sleep-quality signals.No evidence of efficacy for treating insomnia; primary studies were heterogeneous and generally low quality.Not established for insomnia.
ChamomileHuman trials and reviews exist across sleep quality and insomnia-related outcomes.NCCIH says there is no conclusive clinical-trial evidence that chamomile helps insomnia.Inconclusive.
Lavender / aromatherapyAromatherapy reviews report possible sleep-quality improvements across heterogeneous essential-oil studies.Aromatherapy evidence does not establish that oral lavender products treat insomnia; interventions and populations vary.Indirect for an oral-herb claim.

Evidence Snapshot

Evidence: Limited

Ashwagandha

Human evidence
Five placebo-controlled randomized trials / 400 adults were pooled in the 2021 sleep meta-analysis. Trials used defined standardized extracts and repeated dosing over weeks rather than an as-needed bedtime rescue strategy.
Research signal
Stress and neuroendocrine hypotheses may help explain research questions, but symptoms do not diagnose a cortisol problem or identify who should use ashwagandha.
Safety profile
NCCIH notes uncertain long-term safety, rare liver injury, pregnancy/breastfeeding avoidance, thyroid and autoimmune cautions, surgery concerns, and medication interactions.

Evidence Snapshot

Evidence: Limited

Passionflower

Human evidence
A 110-person randomized placebo-controlled trial in adults with DSM-5 insomnia studied passionflower extract for two weeks. Total sleep time improved versus placebo, while several other sleep outcomes did not differ between groups.
Research signal
Sedative or GABA-related mechanisms are hypotheses; they do not establish clinical insomnia efficacy or justify combining passionflower with other sedating products.
Safety profile
NCCIH lists drowsiness, dizziness, and confusion; pregnancy and perioperative cautions apply because of uterine and nervous-system concerns.

Evidence Snapshot

Evidence: Limited

Valerian

Human evidence
The 2024 umbrella review found no evidence of efficacy for treating insomnia, despite some subjective sleep-quality signals across prior reviews.
Research signal
Traditional sedative use and proposed GABA-related effects do not overcome heterogeneous, low-quality clinical evidence.
Safety profile
Long-term safety remains uncertain. Adding valerian to alcohol, sedatives, or multiple calming products can increase complexity and potential sedation risk.

Evidence Snapshot

Evidence: Limited

Chamomile

Human evidence
Trials and pooled reviews exist, but NCCIH still describes the clinical evidence for insomnia as inconclusive.
Research signal
Apigenin-related receptor hypotheses are not equivalent to demonstrated insomnia treatment efficacy.
Safety profile
Chamomile can trigger allergic reactions, especially in people sensitive to ragweed or related plants. Product form and dose also vary substantially.

Why magnesium and L-theanine are not ranked as “herbs” here

Magnesium is a mineral and L-theanine is an amino acid. Both belong in the broader sleep-supplement comparison, where their evidence can be judged without making a botanical ranking look stronger by mixing unlike categories.

Best sleep supplements evidence guide →

Separate herb studies do not validate a sleep stack

Evidence for individual ingredients does not prove that valerian + passionflower, magnesium + ashwagandha, or any other combination is synergistic, faster, or safer. Combining several sedating products also makes benefit, side effects, and interactions harder to attribute.

Sleep stack evidence guide →

Check before using

Safety and stop rules

  • Ashwagandha: avoid during pregnancy/breastfeeding and review thyroid, autoimmune, liver, surgery, and medication issues before use.
  • Passionflower: may cause drowsiness, dizziness, or confusion; avoid during pregnancy and discuss perioperative use because of anesthesia interactions.
  • Chamomile: allergy risk is higher in people sensitive to ragweed or related plants.
  • Valerian and other sedating herbs: long-term safety is uncertain; stacking sedating products increases complexity and may increase impairment.
  • Persistent symptoms: loud snoring/gasping, dangerous daytime sleepiness, restless-legs symptoms, severe mood symptoms, or chronic insomnia warrant evaluation rather than escalating herbs.

Chronic insomnia has a stronger first-line treatment

AASM describes cognitive behavioral therapy for insomnia (CBT-I) as the first-line, evidence-based treatment for chronic insomnia. A botanical comparison should not make supplements look equivalent to that evidence base.

Persistent poor sleep can also reflect sleep apnea, restless legs, circadian disorders, medication effects, mood disorders, substance use, pain, or insufficient sleep opportunity.

Product sourcing note

This broad guide intentionally does not rank affiliate products. Study extracts, teas, essential oils, and retail capsules are not automatically interchangeable. Ingredient-specific evidence pages are the better place to evaluate plant part, extract, preparation, standardization, and independent quality testing.

Frequently asked questions

What is the best herb for sleep?

Current evidence does not support one universal winner. Ashwagandha has a small multi-trial sleep signal from specific standardized extracts. Passionflower has a preliminary two-week insomnia trial. Valerian and chamomile should not be presented as established insomnia treatments, and lavender aromatherapy evidence does not establish that oral lavender products treat insomnia.

Which sleep herb works fastest?

The evidence reviewed here does not establish a reliable same-night winner. Ashwagandha trials generally used repeated dosing over weeks, the passionflower insomnia trial lasted two weeks, and valerian/chamomile evidence is too inconsistent to support a dependable onset promise.

Does valerian work for insomnia?

A 2024 umbrella review found no evidence of efficacy for treating insomnia, despite some subjective sleep-quality signals. The underlying studies were heterogeneous and generally low quality.

Does passionflower help insomnia?

One 110-person randomized placebo-controlled trial in adults with DSM-5 insomnia found a greater increase in total sleep time after two weeks, while several other sleep outcomes did not differ between groups. That is a preliminary signal, not proof of broad insomnia efficacy.

Can sleep herbs be combined?

Separate ingredient studies do not prove that a combination is more effective or safer. Combining sedating products can also make side effects and interactions harder to predict and makes it difficult to identify which ingredient caused benefit or harm.

What should I do if insomnia is chronic?

CBT-I is the first-line evidence-based treatment for chronic insomnia. Persistent sleep problems also warrant evaluation for causes such as sleep apnea, restless legs, circadian disorders, medication effects, mood disorders, substance use, pain, or insufficient sleep opportunity.

Sources and directness notes

  1. 1. NCCIH: Sleep disorders and complementary health approachesCurrent overview of complementary sleep approaches. NCCIH says chamomile evidence is not conclusive, valerian trials are inconsistent and its insomnia value has not been demonstrated, and CBT-I remains the most strongly recommended treatment for insomnia.
  2. 2. Ashwagandha sleep systematic review and meta-analysis (2021)Five placebo-controlled randomized trials / 400 adults. The pooled sleep effect was small with moderate heterogeneity. Trials used specific standardized extracts, populations, and multi-week regimens rather than a generic as-needed herb protocol.
  3. 3. Valerian insomnia umbrella review (2024)Eight systematic reviews were included. The review found no evidence of efficacy for treating insomnia, although some subjective sleep-quality signals appeared; the underlying evidence was heterogeneous and low quality.
  4. 4. Passionflower insomnia randomized placebo-controlled trial (2020)One hundred ten adults with DSM-5 insomnia disorder received passionflower extract or placebo for two weeks. Total sleep time improved versus placebo, while sleep efficiency and wake-after-sleep-onset did not differ significantly between groups.
  5. 5. NCCIH: Passionflower usefulness and safetyNCCIH describes the sleep research as small and mixed. Possible adverse effects include drowsiness, dizziness, and confusion; pregnancy and perioperative cautions apply.
  6. 6. Chamomile systematic review and meta-analysis (2019)Review of randomized and quasi-randomized trials across anxiety, sleep quality, and insomnia outcomes. NCCIH still concludes that clinical evidence is not conclusive for insomnia.
  7. 7. NCCIH: Ashwagandha usefulness and safetySome preparations may help insomnia or stress, but long-term safety is not established. Pregnancy/breastfeeding, thyroid, autoimmune, liver, surgery, and medication-interaction cautions apply.
  8. 8. AASM: cognitive behavioral therapy for insomniaThe American Academy of Sleep Medicine describes CBT-I as the first-line, evidence-based treatment for chronic insomnia.
Ashwagandha for sleep →Sleep herbs vs melatonin →Best sleep supplements →Sleep goal hub →

Free safety checklist

Get future sleep research notes by email

Evidence-first supplement updates, safety context, and new guide announcements. No universal herb rankings or bedtime protocols.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Newsletter

Continue with the newsletter archive

Short notes built for cautious supplement decisions.

Open newsletter

Editorial reading context

How to read Best Herbs for Sleep: What Human Evidence Supports in 2026

Evidence-first guide to ashwagandha, passionflower, valerian, chamomile, and lavender-related sleep evidence, with directness, safety limits, and… This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.

For Best Herbs for Sleep: What Human Evidence Supports in 2026, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.

When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.